Citadel Advisors LLC 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 6:25 pm Purchase |
2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Citadel Advisors LLC | 3,465,307 4.100% |
54,543![]() (+1.60%) |
Filing |
2024-07-22 4:18 pm Purchase |
2024-07-10 | 13G | Terns Pharmaceuticals, Inc. TERN |
Citadel Advisors LLC | 3,410,764 5.300% |
3,410,764![]() (New Position) |
Filing |